首页> 外文会议>NIH Symposium on Therapeutic Oligonucleotides >'Promoter Array' Studies Identify Cohorts of Genes Directly Regulated by Methylation, Copy Number Change, or Transcription Factor Binding in Human Cancer Cells
【24h】

'Promoter Array' Studies Identify Cohorts of Genes Directly Regulated by Methylation, Copy Number Change, or Transcription Factor Binding in Human Cancer Cells

机译:“启动子阵列”研究鉴定了通过甲基化,拷贝数变化或人癌细胞中的转录因子结合直接调节的基因的群组

获取原文

摘要

DNA microarrays of promoter sequences have been developed in order to identify the profile of genes bound and activated by DNA regulatory proteins such as the transcription factors c-Jun and ATF2 as well as DNA-modifying methylases. The arrays contain 3083 unique human promoter sequences from +500 to -1000 nts from the transcription start site. Cisplatininduced DNA damage rapidly leads to specific activation of the Jun kinase pathway leading to increased phosphorylation of c-Jun and ATF2-DNA complexes at hundreds of sites within 3 hours. Using three statistical criteria, approximately 269 most commonly phosphorylated c-Jun/ATF2-DNA complexes were identified and representative cases were verified by qPCR measurement of ChIP-captured DNA. Expression was correlated at the mRNA and protein levels. The largest functional cohort was 24 genes of known DNA repair function, most of which exhibited increased protein expression indicated coordinate gene regulation. In addition, cell lines of prostate cancer exhibit stable methylation or copy number changes that reflect the alterations of the corresponding primary tumors. 504 (18.5%) promoters showed differential hybridization between immortalized control prostate epithelial and cancer cell lines. Among candidate hypermethylated genes in cancer-derived lines, eight had previously been observed in prostate cancer, and 13 were previously determined methylation targets in other cancers. The vast majority of genes that appear to be both differentially methylated and differentially regulated between prostate epithelial and cancer cell lines are novel methylation targets, including PAK6, RAD50, TLX3, PIR51, MAP2K5, INSR, FBN1, GG2-1, representing a rich new source of candidate genes to study the role of DNA methylation in prostate tu-mors. Earlier studies using prototype promoter arrays examine approximately 7% of the proximal regulatory sequences while the current gene regulatory events surveyed here occur on a large scale and may rapidly effect the coordi-nated expression of a large number of genes.
机译:已经开发了促进剂序列的DNA微阵列,以识别由DNA调节蛋白如转录因子C-JUM和ATF2以及DNA改性甲基酶如DNA调节蛋白结合和激活的基因曲线。阵列含有来自转录开始部位的3083个独特的人体启动子序列,从+500到-1000 nts。顺铂诱导的DNA损伤迅速导致Jun激酶途径的特异性活化,导致在3小时内以数百位点增加C-Jun和ATF2-DNA复合物的磷酸化。使用三种统计标准,鉴定了大约269个最常见的磷酸化的C-Jun / ATF2-DNA复合物,并通过QPCR测量芯片捕获的DNA测量来验证代表性病例。表达在mRNA和蛋白质水平上相关。最大的功能队列是已知DNA修复功能的24个基因,其中大多数显示出增加的蛋白质表达表达指出的坐标基因调节。此外,前列腺癌的细胞系表现出稳定的甲基化或拷贝数变化,反映了相应的原发性肿瘤的改变。 504(18.5%)启动子在永生化控制前列腺上皮和癌细胞系之间显示出差异杂交。在癌症衍生的线中的候选高甲基化基因中,先前在前列腺癌中观察到八个,并且先前确定了其他癌症中的甲基化靶标。绝大多数基因似乎含有差异甲基化和差异调节的前列腺上皮和癌细胞系是新的甲基化靶标,包括PAK6,RAD50,TLX3,PIR51,MAP2K5,INSR,FBN1,GG2-1,代表丰富的新型研究DNA甲基化在前列腺Tu-Mors中的作用的候选基因来源。使用原型启动子阵列的早期研究审查了大约7%的近端调节序列,而这里调查的当前基因调节事件发生在大规模上,并且可以迅速影响大量基因的Coordi-Nated表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号